Sitafloxacin (Gracevit) 10 % 30 g

Sitafloxacin is a broad-spectrum antibiotic belonging to the group of fluoroquinalones. It has high efficacy against many Gram-positive, gram-negative and anaerobic clinical isolates, including strains resistant to other fluoroquinolones. It has recently been approved in Japan for the treatment of respiratory and urinary tract infections, as well as Biruli ulcers.

According to the results of randomized, double-blind, multicenter studies, oral sitafloxacin is clinically effective as oral levofloxacin in the treatment of community-acquired pneumonia or infectious exacerbation of chronic respiratory tract disease, as well as oral tosufloxacin in the treatment of community-acquired pneumonia, and as effective as oral levofloxacin in the treatment of complicated urinary tract infections. Incomparable studies have demonstrated the effectiveness of oral sitafloxacin administration in otorhinolaryngological infections, urethritis in men, cervicitis caused by Chlamydia trachomatis in women and odontogenic infections. The most common adverse reactions in patients receiving oral sitafloxacin were gastrointestinal disorders and abnormalities in laboratory parameters.

Release form: granules

Dosage: 100 mg / 1 g

The daily dose is 1 g, in rare cases 2 g as prescribed by a doctor.

Manufacturer Daiichi Sankyo Co., Japan